Psychotropic Drugs, Prevention and Harm Reduction. This item is unavailable.Psychotropic Drugs, Prevention and Harm Reduction

This book promotes the interaction between research and professional practices in the field of prevention and harm reduction. Through the scientific work and experience of human and social sciences researchers and medical social actors, research and action assist one another in illuminating the problems associated with the consumption of psychotropic drugs and in developing intervention strategies.Over the course of several chapters, contributed by attendees of the Psychotropics, Prevention and Harm Reduction Put to the Test By “Human and Social Sciences” workshop, a range of varied themes are explored within the scope of drugs and their uses. Both the socio-historical context of drug uses and the construction of prevention and harm reduction public policies in light of scientific knowledge are covered, as well as the issue of release, mobilization and/or negotiation of prevention and harm reduction standards, both for professionals and drug users.

• Presents acts that formalize the first day of study initiated by the network of young researchers at the Psychotropes and Societies Intervention
• Offers a multidisciplinary view on the understanding of the use of psychotropic substances
• Includes different analyses to stimulate reflection

Imaine Sahed completed her PhD in Sociology from École des Hautes Études en Sciences Sociales in Paris, France in 2016. Her research focuses on psychoactive substance consumption in youth and aims to understand the evolution of drug consumption during adolescence. She is interested in youth health research and promotion.

Antony Chaufton is a Clinical Psychologist and works in a health center, with both adults and adolescents who consume and abuse psychoactive substances. His interest concerns practices that are a risk to the physical, psychological and social body.